INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

53 hedge funds and large institutions have $428M invested in Inozyme Pharma in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.07%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NHAS
1
Novo Holdings A/S
Denmark
$67.5M
2
NMC
2
NEA Management Company
Maryland
$64.3M
3
SI
3
Sofinnova Investments
California
$53.3M
4
RCM
4
RA Capital Management
Massachusetts
$52.7M
5
DM
5
Deerfield Management
New York
$30.2M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$8K 375 +375 New
Millennium Management
52
Millennium Management
New York
$1.06K 40,164 +40,164 New
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$0 10 +10 New
1 2
3